(Alliance News) - London's FTSE 100 is called to open higher, while the dollar and Brent fell as US President Donald Trump announced a ceasefire in the Iran-Israel conflict. Trump said a ceasefire ...

The drug was approved to treat patients who have already received chemotherapy under an accelerated approval process after a ...

AstraZeneca Pharma India, operating in the Pharmaceuticals sector and classified as a Midcap on the BSE, currently has its share price at ₹8904.1. The stock has experienced fluctuations today ...

BENGALURU: Biopharmaceutical company AstraZeneca on Thursday announced the expansion of its global hub in Bengaluru with Rs ...

UK-based global pharma company AstraZeneca and US consumer products company Honeywell have announced a partnership to build a new "next generation" inhaler with a propellant that reduces Global ...

The agency said it will evaluate whether regulatory action is needed after investigating the deaths of two patients treated with Sarepta's therapy.

AstraZeneca spins out a new biotech company, Viela Bio, to focus on six mid-stage autoimmune candidates. ... who will head up R&D and serve as chief medical officer at the biotech.

Technological advances in the design and delivery of mRNA have catalysed the rapid development of mRNA COVID-19 vaccines by ...

Merck announced ACIP voted to recommend Enflosnia (clesrovimab-cfor) as a treatment option for RSV in infants younger than 8 months of age who are born during or entering their first RSV season.

AstraZeneca PLC ADR AZN. Stock XNAS Rating as of Jun 24, 2025. Read Company Report ... Corporate Sustainability. Newsroom. Investor Relations. Get Help; Advertising Opportunities. Feedback.

The deep cuts to Medicaid outlined in President Trump’s budget reconciliation bill would hurt Americans suffering from conditions like chronic obstructive pulmonary disease (COPD), Rep. Maxine Dexter ...

There is a long and ignominious tradition of idiotic comments by ministers thrust into the political centre-stage with no ...